Soteria eDiary (FR)

You are invited to participate in the Acceleron A011-12-FR study. This app is specifically intended for study participants France in the Acceleron A011-12-FR study only. This Phase 3 study is being conducted to assess the long-term safety, tolerability, and efficacy of sotatercept in PAH. Long-term followup of patients receiving sotatercept is important to understand the maintenance and durability of treatment effect (especially in the presence of background PAH therapy) and to provide greater opportunity for pharmacovigilance following sotatercept treatment in the selected patient populations.

Bug fixes and performance improvments.